|
US6713045B1
(en)
|
1995-06-02 |
2004-03-30 |
Research Corporation Technologies, Inc. |
Targeted magnetic resonance imaging agents for the detection of physiological processes
|
|
US6770261B2
(en)
*
|
1995-06-02 |
2004-08-03 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
US5900228A
(en)
|
1996-07-31 |
1999-05-04 |
California Institute Of Technology |
Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
|
|
US6675035B1
(en)
*
|
1997-06-20 |
2004-01-06 |
Imaging Diagnostic Systems, Inc. |
Phantom for optical and magnetic resonance imaging quality control
|
|
KR20010030854A
(ko)
*
|
1997-10-02 |
2001-04-16 |
로퍼, 랜달 비. |
인터벤셔날 요법을 모니터하기 위한 콘트라스트 강화된진단 영상화 방법
|
|
US6713046B1
(en)
|
1997-10-27 |
2004-03-30 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
JP2001521011A
(ja)
*
|
1997-10-27 |
2001-11-06 |
カリフォルニア・インスティテュート・オブ・テクノロジー |
治療成分送達のための磁気共鳴イメージング剤
|
|
WO1999025389A2
(en)
*
|
1997-11-17 |
1999-05-27 |
Research Corporation Technologies, Inc. |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
IT1297035B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
IT1297034B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
US6167297A
(en)
|
1999-05-05 |
2000-12-26 |
Benaron; David A. |
Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
|
|
US6230586B1
(en)
*
|
1999-05-21 |
2001-05-15 |
Chung-Hsi Chang |
Electric drive device for a bicycle
|
|
BR0013171A
(pt)
|
1999-07-29 |
2002-05-28 |
Epix Medical Inc |
Agentes multimericos para formação de imagem de objetivação através de ligação multi-local
|
|
EP1251876A2
(en)
*
|
2000-01-22 |
2002-10-30 |
Epix Medical, Inc. |
Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage
|
|
US6656448B1
(en)
|
2000-02-15 |
2003-12-02 |
Bristol-Myers Squibb Pharma Company |
Matrix metalloproteinase inhibitors
|
|
US6673333B1
(en)
|
2000-05-04 |
2004-01-06 |
Research Corporation Technologies, Inc. |
Functional MRI agents for cancer imaging
|
|
US20040146463A1
(en)
*
|
2000-05-04 |
2004-07-29 |
Meade Thomas J. |
Functional MRI agents for cancer imaging
|
|
AU2001259575A1
(en)
*
|
2000-05-04 |
2001-11-12 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
EP1283728A2
(en)
*
|
2000-05-23 |
2003-02-19 |
Amersham Health AS |
Contrast agents
|
|
US6748259B1
(en)
|
2000-06-15 |
2004-06-08 |
Spectros Corporation |
Optical imaging of induced signals in vivo under ambient light conditions
|
|
US6656450B2
(en)
|
2000-07-17 |
2003-12-02 |
California Institute Of Technology, Inc. |
Macrocyclic magnetic resonance imaging contrast agents
|
|
WO2002028441A2
(en)
|
2000-10-04 |
2002-04-11 |
California Institute Of Technology |
Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
|
|
US20030004236A1
(en)
*
|
2001-04-20 |
2003-01-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
|
|
WO2002087632A1
(en)
*
|
2001-05-02 |
2002-11-07 |
Metaprobe, Inc. |
High throughput screening methods using magnetic resonance imaging agents
|
|
TWI221406B
(en)
|
2001-07-30 |
2004-10-01 |
Epix Medical Inc |
Systems and methods for targeted magnetic resonance imaging of the vascular system
|
|
US20050100963A1
(en)
|
2002-03-01 |
2005-05-12 |
Dyax Corporation |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
CA2666005C
(en)
|
2002-03-01 |
2016-01-19 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
US20030198597A1
(en)
*
|
2002-04-22 |
2003-10-23 |
Meade Thomas J. |
Novel macrocyclic activatible magnetic resonance imaging contrast agents
|
|
AU2003251436A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Bracco Imaging S.P.A. |
Procedures of cellular labelling with paramagnetic complexes for mri applications
|
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
PT2949658T
(pt)
|
2003-03-03 |
2018-10-18 |
Bracco Suisse Sa |
Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
|
|
JP2007528854A
(ja)
*
|
2003-07-09 |
2007-10-18 |
カリフォルニア パシフィック メディカル センター |
細胞への物質送達の遠隔検出
|
|
US20050106100A1
(en)
*
|
2003-09-03 |
2005-05-19 |
Harris Thomas D. |
Compounds containing matrix metalloproteinase substrates and methods of their use
|
|
US20050124008A1
(en)
*
|
2003-12-05 |
2005-06-09 |
Kauvar Lawrence M. |
Homogeneous competition assays
|
|
NO20035683D0
(no)
*
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av prostatakreft
|
|
FR2868320B1
(fr)
*
|
2004-03-31 |
2007-11-02 |
Centre Nat Rech Scient Cnrse |
Agent de contraste pour l'imagerie par resonance magnetique
|
|
CA2602029C
(en)
*
|
2005-03-11 |
2014-07-15 |
Wake Forest University Health Sciences |
Tissue engineered blood vessels
|
|
US9248015B2
(en)
*
|
2005-03-11 |
2016-02-02 |
Wake Forest University Health Services |
Production of tissue engineered heart valves
|
|
US20060204445A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Cell scaffold matrices with image contrast agents
|
|
WO2006099332A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Wake Forest University Health Sciences |
Production of tissue engineered digits and limbs
|
|
US20060204539A1
(en)
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Electrospun cell matrices
|
|
US7531503B2
(en)
*
|
2005-03-11 |
2009-05-12 |
Wake Forest University Health Sciences |
Cell scaffold matrices with incorporated therapeutic agents
|
|
WO2007005491A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Bristol-Myers Squibb Pharma Company |
Hydrazide conjugates as imaging agents
|
|
US9339559B2
(en)
*
|
2005-09-09 |
2016-05-17 |
Georgia State University Research Foundation, Inc. |
Targeted contrast agents and methods for targeting contrast agents
|
|
EP1745739A3
(en)
|
2005-07-14 |
2009-04-22 |
Bundesrepublik Deutschland, vertr. d.d. Bundes- ministerium f. Wirtschaft- und Technologie, dieses vertr. d.d. Präs. d. Phys.-Techn. Bundesanstalt |
Optical imaging of rheumatoid arthritis
|
|
US20080058636A1
(en)
*
|
2005-12-29 |
2008-03-06 |
Epix Pharmaceuticals, Inc. |
Methods of myocardial imaging
|
|
EP4464384A3
(en)
|
2007-08-17 |
2025-01-08 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
JPWO2009054327A1
(ja)
*
|
2007-10-22 |
2011-03-03 |
財団法人大阪産業振興機構 |
Ｍｒｉ用プローブ
|
|
US20120045393A1
(en)
|
2009-03-17 |
2012-02-23 |
Linder Karen E |
Lhrh-ii peptide analogs
|
|
EP2408790A1
(en)
|
2009-03-19 |
2012-01-25 |
Wyeth LLC |
Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof
|
|
WO2010121133A2
(en)
|
2009-04-17 |
2010-10-21 |
The General Hospital Corporation |
Multimodal imaging of fibrin
|
|
JP2011026294A
(ja)
|
2009-06-26 |
2011-02-10 |
Canon Inc |
化合物
|
|
WO2011035140A1
(en)
|
2009-09-18 |
2011-03-24 |
Paka Pulmonary Pharmaceuticals, Inc. |
Methods and compositions for delivery of contrast moieties to the lungs
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CN102188722A
(zh)
*
|
2010-03-18 |
2011-09-21 |
中国科学院福建物质结构研究所 |
一种含二价铁的磁共振成像造影剂
|
|
US8192429B2
(en)
|
2010-06-29 |
2012-06-05 |
Theravant, Inc. |
Abnormality eradication through resonance
|
|
AU2012282678B2
(en)
|
2011-07-11 |
2016-03-03 |
California Institute Of Technology |
Akt-specific capture agents, compositions, and methods of using and making
|
|
KR102057132B1
(ko)
*
|
2012-03-08 |
2019-12-18 |
토멘 메디칼 아게 |
염증성 조직을 진단하기 위한 치과적 용도의 츄잉검
|
|
WO2013131994A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Thommen Medical Ag |
Coating for the diagnosis of inflammatory tissues in dental applications
|
|
BR112015011118B1
(pt)
|
2012-11-15 |
2022-12-13 |
Endocyte, Inc |
Conjugado; composição farmacêutica; e uso de um conjugado
|
|
LT4095130T
(lt)
|
2013-10-18 |
2024-04-25 |
Novartis Ag |
Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti
|
|
US10092679B2
(en)
|
2013-10-18 |
2018-10-09 |
Wake Forest University Health Sciences |
Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
|
|
BR112016010927A2
(pt)
|
2013-11-14 |
2017-08-08 |
Endocyte Inc |
Conjugado de fórmula
|
|
WO2015171543A1
(en)
|
2014-05-05 |
2015-11-12 |
California Institute Of Technology |
Mutant akt-specific capture agents, compositions, and methods of using and making
|
|
WO2015196208A2
(en)
|
2014-06-20 |
2015-12-23 |
The General Hospital Corporation |
Collagen targeted imaging probes
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
EP3270951B1
(en)
|
2015-03-16 |
2020-09-09 |
California Institute of Technology |
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
|
|
CN115112898B
(zh)
|
2015-07-15 |
2026-03-24 |
加州理工学院 |
Il-17f-特异性捕获剂、组合物以及使用和制造的方法
|
|
CN115109120A
(zh)
|
2016-04-04 |
2022-09-27 |
英蒂分子公司 |
Cd8-特异性捕获剂、组合物及使用和制备方法
|
|
US11884707B2
(en)
|
2016-09-29 |
2024-01-30 |
Regeneron Pharmaceuticals, Inc. |
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
|
|
EP3535278A4
(en)
|
2016-11-01 |
2020-06-24 |
Ohio State Innovation Foundation |
METHOD FOR IODING BIOMOLECULES
|
|
US20200046859A1
(en)
*
|
2017-04-27 |
2020-02-13 |
The Regents Of The University Of California |
Modified mri contrast agents and uses thereof
|
|
EP3638687A1
(en)
|
2017-06-15 |
2020-04-22 |
Indi Molecular, Inc. |
Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
|
|
WO2019075213A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Northwestern University |
HEPARIN CONJUGATED TO PEPTIDES BINDING TO COLLAGEN FOR TARGETING BIOLOGICAL AND SYNTHETIC FABRICS
|
|
CN108314695B
(zh)
*
|
2018-01-04 |
2020-06-16 |
南京邮电大学 |
一种异种双核金属配合物的制备及应用
|
|
US12208102B2
(en)
|
2018-04-17 |
2025-01-28 |
Endocyte, Inc. |
Methods of treating cancer
|
|
WO2020093055A2
(en)
|
2018-11-02 |
2020-05-07 |
Indi Molecular, Inc. |
Peptide libraries with non-canonical amino acids
|
|
US11638764B2
(en)
|
2018-11-08 |
2023-05-02 |
Indi Molecular, Inc. |
Theranostic capture agents, compositions, and methods of using and making
|
|
WO2020186091A1
(en)
|
2019-03-12 |
2020-09-17 |
Indi Molecular, Inc. |
Cross-linked epitopes and methods of use thereof
|
|
US12201679B2
(en)
|
2019-04-05 |
2025-01-21 |
Institute For Systems Biology |
Epitope-targeted peptide immunostimulants
|
|
WO2020236969A1
(en)
|
2019-05-20 |
2020-11-26 |
Indi Molecular, Inc. |
Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
|
|
CN114096264B
(zh)
|
2019-05-20 |
2025-03-14 |
因多塞特股份有限公司 |
制备psma缀合物的方法
|
|
EP3972646A4
(en)
|
2019-05-20 |
2023-06-14 |
Ohio State Innovation Foundation |
APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USE THEREOF
|
|
US11414460B2
(en)
|
2019-07-19 |
2022-08-16 |
Institute For Systems Biology |
KRAS-specific capture agents, compositions, and methods of making and using
|
|
CN112891566A
(zh)
*
|
2019-12-04 |
2021-06-04 |
中国科学院宁波工业技术研究院慈溪生物医学工程研究所 |
一种纳米材料及其制备方法和包含其的造影剂
|
|
EP4143227A2
(en)
|
2020-04-30 |
2023-03-08 |
Sairopa B.V. |
Anti-cd103 antibodies
|
|
US12209142B2
(en)
|
2020-05-29 |
2025-01-28 |
Institute For Systems Biology |
SARS-CoV-2 epitope-targeted peptide immunostimulants
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
CN120093699B
(zh)
*
|
2025-03-06 |
2025-11-14 |
浙江大学 |
用于定位并稳定动脉粥样硬化斑块的诊疗分子、纳米粒及其制备方法
|